Sabine Schaedelin
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Todea A, Melie-Garcia L, Barakovic M, Cagol A, Rahmanzadeh R, Galbusera R, Lu P, Weigel M, Ruberte E, Radue E, Schaedelin S, Benkert P, Oezguer Y, Sinnecker T, Müller S, Achtnichts L, Vehoff J, Disanto G, Findling O, Chan A, Salmen A, Pot C, Lalive P, Bridel C, Zecca C, Derfuss T, Remonda L, Wagner F, Vargas M, Du Pasquier R, Pravatà E, Weber J, Gobbi C, Leppert D, Wuerfel J, Kober T, Marechal B, Corredor-Jerez R, Psychogios M, Lieb J, Kappos L, Cuadra M, Kuhle J, Granziera C. A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients. J Magn Reson Imaging 2023
Jan 28, 2023A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis Patients.
Jan 28, 2023J Magn Reson Imaging 2023
Todea Alexandra Ramona, Melie-Garcia Lester, Barakovic Muhamed, Cagol Alessandro, Rahmanzadeh Reza, Galbusera Riccardo, Lu Po-Jui, Weigel Matthias, Ruberte Esther, Radue Ernst-Wilhelm, Schaedelin Sabine, Benkert Pascal, Oezguer Yaldizli, Sinnecker Tim, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Disanto Giulio, Findling Oliver, Chan Andrew, Salmen Anke, Pot Caroline, Lalive Patrice, Bridel Claire, Zecca Chiara, Derfuss Tobias, Remonda Luca, Wagner Franca, Vargas Maria I, Du Pasquier Renaud, Pravatà Emanuele, Weber Johannes, Gobbi Claudio, Leppert David, Wuerfel Jens, Kober Tobias, Marechal Benedicte, Corredor-Jerez Ricardo, Psychogios Marios, Lieb Johanna, Kappos Ludwig, Cuadra Meritxell Bach, Kuhle Jens, Granziera Cristina
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Benkert P, Meier S, Schaedelin S, Manouchehrinia A, Yaldizli O, Maceski A, Oechtering J, Achtnichts L, Conen D, Derfuss T, Lalive P, Mueller C, Müller S, Naegelin Y, Oksenberg J, Pot C, Salmen A, Willemse E, Kockum I, Blennow K, Zetterberg H, Gobbi C, Kappos L, Wiendl H, Berger K, Sormani M, Granziera C, Piehl F, Leppert D, Kuhle J. Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study. Lancet Neurol 2022; 21:246-257.
Mar 1, 2022Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
Mar 1, 2022Lancet Neurol 2022; 21:246-257
Benkert Pascal, Meier Stephanie, Schaedelin Sabine, Manouchehrinia Ali, Yaldizli Ozgür, Maceski Aleksandra, Oechtering Johanna, Achtnichts Lutz, Conen David, Derfuss Tobias, Lalive Patrice H, Mueller Christian, Müller Stefanie, Naegelin Yvonne, Oksenberg Jorge R, Pot Caroline, Salmen Anke, Willemse Eline, Kockum Ingrid, Blennow Kaj, Zetterberg Henrik, Gobbi Claudio, Kappos Ludwig, Wiendl Heinz, Berger Klaus, Sormani Maria Pia, Granziera Cristina, Piehl Fredrik, Leppert David, Kuhle Jens
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Oechtering J, Naegelin Y, Maceski A, Meier S, Berger K, Wiendl H, Lincke T, Lieb J, Yaldizli O, Sinnecker T, Derfuss T, Regeniter A, Zecca C, Gobbi C, Kappos L, Granziera C, Leppert D, Kuhle J, Conen D, Aeschbacher S, Subramaniam S, Schaedelin S, Benkert P, Müller S, Achtnichts L, Vehoff J, Giulio D, Findling O, Fischer-Barnicol B, Orleth A, Chan A, Pot C, Barakovic M, Rahmanzadeh R, Galbusera R, Heijnen I, Lalive P, Wuerfel J, Swiss Multiple Sclerosis Cohort Study. Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis. Ann Neurol 2021; 90:477-489.
Jun 22, 2021Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
Jun 22, 2021Ann Neurol 2021; 90:477-489
Oechtering Johanna, Naegelin Yvonne, Maceski Aleksandra, Meier Stephanie, Berger Klaus, Wiendl Heinz, Lincke Therese, Lieb Johanna, Yaldizli Ozgür, Sinnecker Tim, Derfuss Tobias, Regeniter Axel, Zecca Chiara, Gobbi Claudio, Kappos Ludwig, Granziera Cristina, Leppert David, Kuhle Jens, Conen David, Aeschbacher Stefanie, Subramaniam Suvitha, Schaedelin Sabine, Benkert Pascal, Müller Stefanie, Achtnichts Lutz, Vehoff Jochen, Giulio Disanto, Findling Oliver, Fischer-Barnicol Bettina, Orleth Annette, Chan Andrew, Pot Caroline, Barakovic Muhamed, Rahmanzadeh Reza, Galbusera Riccardo, Heijnen Ingmar, Lalive Patrice H, Wuerfel Jens, Swiss Multiple Sclerosis Cohort Study
Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial
Traenka C, Engelter S, Lyrer P, Psychogios M, Stippich C, Brehm A, Sztaizel R, Rosenbaum S, Kellert L, Nolte C, Kahles T, Kägi G, Michel P, Arnold M, Luft A, Schaedelin S, Gensicke H, TREAT-CAD investigators. Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial. Eur Stroke J 2020; 5:309-319.
Jun 29, 2020Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial
Jun 29, 2020Eur Stroke J 2020; 5:309-319
Traenka Christopher, Engelter Stefan T, Lyrer Philippe, Psychogios Marios, Stippich Christoph, Brehm Alex, Sztaizel Roman, Rosenbaum Sverre, Kellert Lars, Nolte Christian H, Kahles Timo, Kägi Georg, Michel Patrik, Arnold Marcel, Luft Andreas, Schaedelin Sabine, Gensicke Henrik, TREAT-CAD investigators